awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34673567-23A3EB4D-F352-4593-A540-B953E934B44B
Q34673567-23A3EB4D-F352-4593-A540-B953E934B44B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34673567-23A3EB4D-F352-4593-A540-B953E934B44B
Biomarkers of response and resistance to antiangiogenic therapy.
P2860
Q34673567-23A3EB4D-F352-4593-A540-B953E934B44B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34673567-23A3EB4D-F352-4593-A540-B953E934B44B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3fb63dd5ea3d2a2462accfdcb4eb1e990a9aec0a
P2860
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors.